EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy‐related inflammation: A systematic analysis of published and seven new cases

Levente Szalardy, Bernadett Fakan, Rita Maszlag-Torok, Emil Ferencz, Zita Reisz, Bence L Radics, Sandor Csizmadia, Laszlo Szpisjak, Adam Annus, Denes Zadori, Gabor G Kovacs iD, Peter Klivenyi iD

Neuropathology and Applied Neurobiology · 2024-02 · 50 (1)

DOI: 10.1111/nan.12946 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 15.02.2024. Verfasst von Levente Szalardy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Albert Szent-Györgyi Medical School, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian National Research, Development and Innovation Office, Hungarian National Research, Development and Innovation Fund, University of Szeged.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cerebral amyloid angiopathy (CAA)‐related inflammation (CAA‐RI) is a potentially reversible manifestation of CAA, histopathologically characterised by transmural and/or perivascular inflammatory infiltrates. We aimed to identify clinical, radiological and laboratory variables capable of improving or supporting the diagnosis of or predicting/influencing the prognosis of CAA‐RI and to retrospectively evaluate different therapeutic approaches.

Methods

We present clinical and neuroradiological observations in seven unpublished CAA‐RI cases, including neuropathological findings in two definite cases. These cases were included in a systematic analysis of probable/definite CAA‐RI cases published in the literature up to 31 December 2021. Descriptive and associative analyses were performed, including a set of clinical, radiological and laboratory variables to predict short‐term, 6‐month and 1‐year outcomes and mortality, first on definite and second on an expanded probable/definite CAA‐RI cohort.

Results

Data on 205 definite and 100 probable cases were analysed. CAA‐RI had a younger symptomatic onset than non‐inflammatory CAA, without sex preference. Transmural histology was more likely to be associated with the co‐localisation of microbleeds with confluent white matter hyperintensities on magnetic resonance imaging (MRI). Incorporating leptomeningeal enhancement and/or sulcal non‐nulling on fluid‐attenuated inversion recovery (FLAIR) enhanced the sensitivity of the criteria. Cerebrospinal fluid pleocytosis was associated with a decreased probability of clinical improvement and longer term positive outcomes. Future lobar haemorrhage was associated with adverse outcomes, including mortality. Immunosuppression was associated with short‐term improvement, with less clear effects on long‐term outcomes. The superiority of high‐dose over low‐dose corticosteroids was not established.

Conclusions

This is the largest retrospective associative analysis of published CAA‐RI cases and the first to include an expanded probable/definite cohort to identify diagnostic/prognostic markers. We propose points for further crystallisation of the criteria and directions for future prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathyHumansCerebral HemorrhageInflammationMagnetic Resonance ImagingPrognosisProspective StudiesRetrospective Studies

Stichwörter der Autor:innen

amyloid-β-related angiitiscerebral amyloid angiopathycerebral amyloid angiopathy-related inflammationcriteriadiagnosisinflammatory cerebral amyloid angiopathyoutcomepredictor

Autor:innen und Institutionen

  • Department of Neurology, Albert Szent-Györgyi Medical School, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.
  • Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Pathology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.
  • Department of Clinical Neuropathology, King's College Hospital, London, UK.
  • Affidea Hungary Ltd., Budapest, Hungary.
  • Laboratory Medicine Program and Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Gabor G Kovacs, Peter Klivenyi

Förderung

  • Hungarian National Research, Development and Innovation Office
  • Hungarian National Research, Development and Innovation Fund
  • University of Szeged
  • Hungarian Academy of Sciences
  • Hungarian Ministry for Innovation and Technology
  • National Talent Program
  • University of Szeged Open Access Fund

Zitieren

APA

Szalardy, L., Fakan, B., Maszlag-Torok, R., Ferencz, E., Reisz, Z., Radics, B. L., Csizmadia, S., Szpisjak, L., Annus, A., Zadori, D., Kovacs, G. G., & Klivenyi, P. (2024). Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy‐related inflammation: A systematic analysis of published and seven new cases. Neuropathology and Applied Neurobiology, 50(1). https://doi.org/10.1111/nan.12946

Vancouver

Szalardy L, Fakan B, Maszlag-Torok R, Ferencz E, Reisz Z, Radics BL, et al. Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy‐related inflammation: A systematic analysis of published and seven new cases. Neuropathology and Applied Neurobiology. 2024;50(1). doi:10.1111/nan.12946

BibTeX
@article{Szalardy2024,
  author = {Szalardy, Levente and Fakan, Bernadett and Maszlag-Torok, Rita and Ferencz, Emil and Reisz, Zita and Radics, Bence L and Csizmadia, Sandor and Szpisjak, Laszlo and Annus, Adam and Zadori, Denes and Kovacs, Gabor G and Klivenyi, Peter},
  title = {Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy‐related inflammation: A systematic analysis of published and seven new cases},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2024},
  volume = {50},
  number = {1},
  doi = {10.1111/nan.12946}
}
Kostenlos starten →